Caroline Johnson MP: speeches

Speeches

• 10 Mar 2026 · Courts and Tribunals Bill · Hansard source

  More

  That is why I have explained that the presumption is that the parents have involvement. The court must take the risks to the child into consideration and, unless shown otherwise, give contact to both parents. If the child is at risk, however, the court has the absolute right to prevent the child from seeing those parents or to restrict contact to different forms and timeframes. The welfare of the child is key in those decisions. That is in line with international law, which I know the Government are fond of. The UN convention on the rights of the child says that parents and children should maintain “personal relations and direct contact with both parents on a regular basis, except if it is contrary to the child’s…interests.”

• 9 Mar 2026 · Type 1 Diabetes: Infant Testing · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Sir Alec. I declare an interest as an NHS consultant paediatrician and a member of the Royal College of Paediatrics and Child Health. I congratulate the Minister on her new role. It is a very important role in the Government, and I know that she will do it with great care and thoughtfulness. I congratulate the hon. Member for North Ayrshire and Arran (Irene Campbell) on introducing this important debate. I also give condolences to Lyla’s family and commend them on their bravery and their courage. I pay tribute to their work to prevent the same tragedy from happening to other families. When one becomes a doctor, one gets trained in resuscitation. Many people are familiar with the resuscitation ABC—“airway, breathing, circulation”—but the full version is ABCDEFG: “airway, breathing, circulation, don’t ever forget glucose.” Sadly, some people do, as we have heard today. Every doctor is taught the signs of diabetes mellitus, what to look for and when to test sugar. I am hesitant to legislate medical guidance, because that still requires the awareness of the guidance’s existence. Changing the guidance in law instead of simply in practice may also reduce flexibility as evidence-based judgment comes to the fore. What is the Minister doing to increase awareness among doctors and wider clinical teams, as well as families and the wider public, so that we do not see cases of tragedy and near misses like those that we have heard about today? Diabetes type 1 can present at any age, but it commonly presents in primary school and the early years of secondary school. Detection before it develops is challenging, and presentation is often very acute in children. It is an autoimmune condition, so antibodies are developed by the insulin-producing cells in the pancreas, creating a deficiency in insulin, which is the cause of the illness. The ELSA study, which has been mentioned, is looking at how we can detect that before a child becomes sick. It will look at 70,000 children. It starts with a simple finger-prick test, similar to that for sugar. It tests for three antibodies; if the person has any of those, they get a second test for four antibodies. We know that if they have two or more of those antibodies, their chance of becoming diabetic in the next 10 years is 75%. We also know that a medication called teplizumab, which was licensed in August 2025 for children over eight years old, may be able to prolong that time. There may be opportunities for further awareness and investigation for early diagnosis, but also for further drugs to be developed, which can delay the onset of diabetes in people who are susceptible to it. The analysis for the first 17,000 patients showed that 75 children had one antibody and 160 had two antibodies. One of the challenges is determining the best age to test. When did these antibodies develop? What do they develop in response to? Does the test need repeating? If so, how often? I commend my hon. Friend the Member for South Northamptonshire (Sarah Bool) for her ten-minute rule Bill, which will provide leadership on those very important questions. I also want to ask the Minister about diabetes treatment. For those who are diabetic, blood sugar control is a lifelong preoccupation, as my hon. Friend described. This is not just about the short-term risks of hypoglycaemia and diabetic ketoacidosis, although those are serious enough; the long-term complications from poor diabetic control include heart failure, strokes, amputation and blindness. The latest report from the Royal College of Paediatrics and Child Health showed that there were 33,437 children in England with diabetes mellitus, of whom 93.3% have type 1. These children have regular health checks, but only 66% of the over-12s receive those health checks. What is the Minister doing to increase the proportion? Haemoglobin A1c, or HbA1c, is a chronic measure of what the sugar level has been over time. It is 70.8 in black children, compared with 63.1 in white children and 63.9 in Asian children. What is the Minister’s understanding of what causes that disparity and what is she doing to improve the HbA1c in all children? Technology can really help. The latest figures from an RCPCH study in this area, from 2023-24, show that continuous glucose monitoring of children increased from 49% to 79%, insulin pump usage increased from 45% to 56% in a year, and the use of the hybrid closed loop system increased from 15% to 36% in just one year. Such devices really improve diabetic control. What are the Government doing to increase the rollout of these technologies? No one in this House wants to see any child become very sick or to see any family suffer the heartache that Lyla’s family have suffered. I pay tribute once again to Lyla’s family. This debate, the petition and the media reporting of this debate will all raise awareness, and I have no doubt that that will contribute to saving the life of some child somewhere in our nation. I look forward to hearing the Minister’s response on how she will increase clinician awareness and widen public awareness, improve research into screening and new treatments, improve early diagnosis, and roll out the best technologies and treatments to improve diabetic control for patients with diabetes.

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  Can the Minister confirm that the vaccine group direction—unlike a patient group direction, which ultimately needs to be signed by a clinician—would not need to be signed by a clinician, and can instead be signed by a senior manager either within a company or department?

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  Before the Minister moves on, can I just ask him why ODPs appear to have been removed from the list?

• 3 Mar 2026 · Draft Human Medicines (Amendment) Regulations 2026 · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Mrs Harris. The Opposition do not intend to divide the Committee on these regulations, as anything that improves trust in medicines and vaccines is important. We need to increase the uptake of vaccines; it has fallen gradually and continues to fall, and we need to reverse that. I have a couple of technical questions. As the Minister said, the principle behind the amendment to regulation 3 of the 2012 regulations is to make prescribing pharmacists equivalent to doctors and dentists. However, regulation 3(8) currently refers to, “another doctor or dentist…of the same…practice.” Given that pharmacists will now also be included, should that be amended to “another doctor, dentist or pharmacist”, or “a doctor or dentist”? Regulation 5 redefines an “occupational health vaccinator” and refers to a list in part 4 of schedule 16 to the 2012 regulations. That significantly broadens the list to include individuals such as speech and language therapists who are not accustomed to dealing with injectable medications, but appears to exclude operating department practitioners, who, as the Minister will be aware of from his practice, are used to dealing with injectable medications. Could the Minister explain the reason for removing those practitioners from the list? Regulations 8 and 9 talk about the vaccine group direction. The patient group direction is essentially a group prescription, where a clinician signs off the circumstances in which medication—say, paracetamol —may be given by a non-prescriber. We had such a direction for the covid-19 vaccine during the pandemic. This vaccine group direction would be different, so why does the Minister feel that we need a different process to the patient group direction that is already available for vaccines, which are prescription medicines? Instead, those directions can be signed by someone who is not a clinician—such as a manager in the Department of Health or, in fact, a private company—and they do not need to have any clinical skills or qualifications at all. A clinician, or one of the people listed, must decide whether the conditions have been met, and they can then give the patient the medicine without having prescribed it. I want to ask a couple of questions on this issue. How does that improve trust, when we have a vaccine-sceptic population and lots of material on social media, some of which is not entirely accurate? How does allowing a prescription to be written by someone with no clinical experience help with trust and those rates? Is there a plan to contract out vaccine provision to the private sector, because that is what this provision allows for? Who is ultimately responsible? Is it the non-clinician who signs the vaccine group direction? Who is the clinician ultimately responsible for the decision to give the vaccine in the event that someone has an allergic reaction or an adverse reaction of some other type?

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  I am sorry. The last Government’s work to channel more resources into mental health could not have been more welcome. This year, 2025-26, will be the first since 2016-17 that mental health spending has not risen as a proportion of health spending. That contravention of the mental health investment standard has raised alarm bells at the Health and Social Care Committee. Can the Minister enlighten us as to why the Government have decided to break the mental health investment standard after nearly a decade of progress? Does he think the percentage is now about right? Does it concern him that some ICBs have cut funding for mental health services? How does he expect that to impact on patients suffering from eating disorders? I am particularly concerned about the impact on children and young people, and I declare an interest as a consultant NHS paediatrician. Some 6.4% of adults have a diagnosed eating disorder, but 12.5% of 17 to 19-year-olds have been diagnosed with an eating disorder since 2023. That amounts to one in five girls in that age group—four times the prevalence in boys. What specific action is the Minister taking to improve early intervention? The previous Government got the ball rolling on establishing mental health support teams in schools, and had reached 35% coverage by the time of the general election, with a commitment to increase that to 100% of schools and colleges in England by 2030. Does the Minister plan to build on that work? What further action is he taking to improve links between eating disorder services, schools and families to ensure a joined-up approach to accessing specialist help and early diagnosis, which, as we have heard, is critical? The hon. Member for Didcot and Wantage (Olly Glover) spoke of the challenges of transition. As a paediatrician, I see the challenges of transitioning many paediatric and adolescent conditions between children’s and adult services, but can the Minister say what he is doing specifically for those transitioning with eating disorders? In my role as chair of the APPG on emerging drugs and online behavioural trends, I know the effect of social media on children’s and young people’s behaviours. Researchers from University College London, who examined evidence from 50 studies in 17 countries, found that social media usage is linked to eating disorders in young people, as it viciously promotes the idea that it is essential to be thin and fit, triggering a potentially extreme preoccupation with body image, weight and shape. Those obsessions are compounded by AI content, which can depict simply unachievable so-called perfection. As the hon. Member for Bath said, there are harmful videos online, with algorithms driving that harm, and those who look at these things seeing them more and more. I recently held a policy debating competition among year 10 and year 12 students in my constituency, where students chose the topic of debate. Many of them spoke in favour of a social media ban for children as young as 16. It is a difficult issue, and that is not a perfect solution, but having just got a new mobile phone myself, I wonder why, when someone buys a phone, it cannot be set at a fixed age that can be changed only by the adult who pays the bill. A change in the law to restrict social media for under-16s would help to reduce that problem. I am interested in the Minister’s thoughts on that. NHS guidance on eating disorders for ICBs has been raised in the debate. The NHS has refreshed that guidance, which is welcome, but patients will feel the difference only if it is actually implemented. The Minister has confirmed that there will not be a dedicated strategy for eating disorders, and there is no mention at all of eating disorders in the 70,000-word 10-year plan. Is the Minister confident that the refreshed guidance for ICBs will be sufficient on its own to improve care for people with eating disorders and to get waiting lists down? Does he have a strategy for how it will be enforced? We have talked about the effects on families and carers. What action is the Minister taking to engage families, carers and supportive charities in plans for care? What support is available for parents, carers and siblings? Workforce is key to delivering this strategy. We know that waiting times for eating disorder treatment are getting worse; analysis from Beat found that, in some cases, people with eating disorders face a three-and-a-half-year delay between falling ill and starting treatment. For someone with an eating disorder, that is three and a half years deeper into the illness. As we have heard, that makes it all the more difficult to treat the patient effectively and quickly pull them out of that difficult, dark place. What steps is the Minister taking to increase workforce capacity to help treat these patients and restore some stability and normality to their lives? I feel as though I ask this question every time, but the NHS long-term workforce plan is still not with us, having been delayed from last year, so when will it be published, and what tangible action will it take to boost the NHS eating disorders service? It is not just about hiring more staff; it is also about where we are hiring them. That is important work, but more needs to be done to build on the progress. The Healthcare Quality Improvement Partnership produced a highly detailed report about in-patient eating disorder service provision in the UK. As expected, there were blackspots for those vital services in many rural and coastal areas, such as in Lincolnshire. For adults and families in constituencies such as mine, where the closest service may be an hour’s car journey away, accessing eating disorder services is remarkably difficult. The Government have been insistent that rural and coastal areas will not be left behind on healthcare, but the blackspots tell us otherwise.

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  I completely agree. This is not just about people who have a car; for people who do not have a car and who are reliant on public transport, it can be even more difficult. People also struggle to take time off work because of the financial cost. For those who do have a car, there is also the cost of the petrol or diesel to get to the appointment. I would appreciate it if the Minister could update us on what he is doing to ensure that the neighbourhood and community slant of the three pillars of his health improvement plan are working in that regard. As the hon. Member for Bath said, in-patient services are limited in capacity. In my paediatric practice, I have seen patients waiting on acute general paediatric wards—sometimes for several weeks—but those are really not the right place for them to be cared for. Could the Minister update us on what he is doing about increasing capacity in regional services? I would like to speak a little about two other types of eating disorder: avoidant/restrictive food intake disorder and Prader-Willi syndrome. ARFID involves limiting the amount or variety of food consumed. It is not just picky eating. I have seen a teenager who lives on just plain pasta, nuggets and chips, and a younger boy who lives on a single flavour of one brand of milkshake and no solid food at all. That can be driven by fear and sensory and other issues. What is the Minister doing to make sure that services are available for these young children? NHS England’s refreshed eating disorder guidance recommends: “ICBs should develop and deliver ARFID care pathways”. What steps is the Minister taking to improve early diagnosis of ARFID, and what work will be done to train primary carers to identify it in children and adults, particularly in cases of neurodivergence? Prader-Willi syndrome is a rare genetic disorder causing excessive appetite and overeating, which can lead to dangerous weight gain and restricted growth. Around 2,000 people live with Prader-Willi syndrome in the UK, and there is no cure. It is not mentioned in the NHS guidance, so what work is the Minister doing to ensure that people suffering from PWS have access to the care they need? What steps are we taking to expand genetic testing at birth to identify PWS and improve early access to treatment for these patients? To sum up, mental health challenges are on the rise, and eating disorders are no exception. I urge the Minister to implement a clear approach to tackling eating disorders for adults, children and young people.

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  It is a pleasure to serve under your chairmanship, Ms Vaz. I congratulate the hon. Member for Bath (Wera Hobhouse) on securing this important debate and on her work in this area. Eating disorders are deeply complex conditions. On the surface, disordered eating can take a variety of forms, including restricting the amount or the type of food eaten; binge eating large amounts of food in a short period and then purging that food through forced vomiting; excessive exercise; and laxative misuse to avoid weight gain. Beneath that surface lay a horde of drivers, such as control, shame, anxiety, obsessive-compulsive disorder, poor body image, and mysophobia, which is also known as germophobia. The covid pandemic provoked intense scrutiny of germs and cleanliness, took away people’s control over when they could go out and when they could see their friends, and drove their activities from the personal to the online, so it comes as no surprise that it saw a spike in eating disorder referrals. By early 2021-22, 3,400 people were treated for an eating disorder, compared with 1,900 in the same period in 2019-20. The last Government introduced the mental health investment standard to increase mental health spending in local health systems, and it also included a pledge to increase mental health spending as a proportion of total health spending every year. With mental health accounting for over 20% of demand for health services, and a 2021 report finding that eating disorders cost the UK economy a £9.4 billion per year—

• 26 Feb 2026 · Eating Disorders Awareness Week · Hansard source

  More

  The Minister’s speech is very interesting. He talks about an increase in capacity, much of which will require workforce. I noticed that when he mentioned the workforce plan, he said “spring or early summer”, which is a change from his previous wording, which was always “spring”. Is that a sign that it is being delayed further?

• 24 Feb 2026 · Preventing Ill Health · Hansard source

  More

  I declare an interest as a consultant paediatrician in the NHS. Prevention of ill health is crucial. It is particularly important in children, perhaps most especially when one is trying to prevent ill health in children caused by doctors. I have expressed concerns previously about the puberty blockers trial, as have many in both Houses. The trial has now been paused due to a Medicines and Healthcare products Regulatory Agency letter. When were Ministers first aware of that letter and when were they first aware of the concerns described within it?

• 24 Feb 2026 · Preventing Ill Health · Hansard source

  More

  That is a very interesting answer. Before Christmas, the Secretary of State had confidence in an allegedly vigorous and rigorous process. Fertility preservation techniques have not deteriorated over the last few months. The ages at which children reach the Tanner stages of puberty have not changed over the last few months, but the MHRA’s view has. Why? Given that this is such a scrutinised trial, does that not call into question the MHRA’s wider competence and due diligence? Will the Minister publish the MHRA’s letter from November referred to in the more recent correspondence published on Friday?

• 11 Feb 2026 · Hughes Report: Second Anniversary · Hansard source

  More

  It is an honour to serve under your chairmanship, Dr Allin-Khan. On behalf of the Opposition, I thank the hon. Member for Chesham and Amersham (Sarah Green) for securing today’s debate. She has campaigned tirelessly on this issue, giving a voice to thousands of women who have been let down by the state. I also thank Henrietta Hughes for the Hughes report. Thousands of pregnant women were prescribed sodium valproate between 1973 and 2017 despite growing evidence of harm. In 1972, scientists found in animal studies that it was harmful to foetuses, and in 1984, foetal valproate syndrome entered the medical literature. Studies in the 2000s highlighted the link between valproate and birth defects. I remember, as perhaps you do, Dr Allin-Khan, learning about it at medical school. Yet it was only in 2018 that the valproate pregnancy prevention programme came into force, which was too late for more than 20,000 children with entirely preventable disability. Over 10,000 women in England were harmed by pelvic mesh. Mesh kits were issued in the 2000s to treat urinary incontinence and prolapse, despite a lack of long-term safety data. Women suffered hideous complications: mesh tearing through tissue, bleeding, infection and sexual dysfunction. Shockingly, it took until 2018 for NHS England to suspend the routine use of these implants. I want to raise the case of a lady, now in her 30s, who had a mesh implant put in to prevent a hernia in her abdominal wall, something that is often missed from the discussions about mesh. She describes how she is unable to leave her home because there is a hole in her stomach wall where the mesh has eroded. It cannot be removed. The surgeon described it as being stuck in there like chewing gum. She described her wish for a family. She described the smell of the constant infections. She described the fear of waiting for the next infection and wondering whether the sepsis from it will kill her. Yet there seems to be no way for her to get this mesh removed. The previous Government did not sit on their hands. The former Health Secretary, my right hon. Friend the Member for Godalming and Ash (Sir Jeremy Hunt), commissioned the independent medicines and medical devices safety review after hearing from over 700 affected people and medical stakeholders. The previous Government issued a formal apology to victims and appointed a Patient Safety Commissioner. They began to establish a network of centres to provide treatment, care and advice for those affected by the implanted mesh. I would be grateful for an update on that from the Minister, particularly in the light of the case that I described. In 2022, the previous Government asked the new commissioner to report on options for compensating victims. Dr Henrietta Hughes did so in February 2024, a full 24 months ago, and that report set out what justice should look like for victims: an interim redress scheme and a permanent one to follow. As my right hon. Friend the Member for New Forest East (Sir Julian Lewis) said, it was a package of clear, practical steps to right the wrongs done to so many women. Yet two years on, we are no further forward. After the 2024 election, the hon. Member for Chesham and Amersham asked the Government when they would respond to the Hughes report. The response was that the Government would consider the recommendations and meet with the commissioner. In January 2025, when asked by Baroness Ritchie of Downpatrick, the Government said they were “carefully considering” report and would provide an update “at the earliest opportunity.” In March, in this very room, a Government Minister said that recommendations were being actively considered and that a report was coming “at the earliest opportunity.” In that debate, the Minister suggested that research by Dr Rebecca Bromley was material. Can the Minister update us on that research? In October, when the hon. Member for Rushcliffe (James Naish) asked whether funding had been allocated for redress, a Minister said that recommendations were being carefully considered and a response would come at the earliest opportunity. In December, when the shadow Secretary of State for Health and Social Care, my right hon. Friend the Member for Daventry (Stuart Andrew), asked whether financial support was forthcoming, the Government said that recommendations were—still—being carefully considered. Last month, when my hon. Friend the Member for Harrow East (Bob Blackman) asked whether funding was forthcoming, a Minister said the Government were “carefully considering” the report and an update was coming “in due course”. What we have heard from Ministers is so frustrating. For 18 months, Members have asked what is being done, and time and again, this Labour Government have refused to give a clear answer. I note that the previous debate was responded to by the Under-Secretary of State for Health and Social Care, the hon. Member for West Lancashire (Ashley Dalton), and both she and the Under-Secretary of State for Health and Social Care, the hon. Member for Glasgow South West (Dr Ahmed), have answered questions on the matter. We have a different Minister today, and it is a delight to see her, but perhaps she can confirm which Minister takes responsibility for this issue in the Commons. I have some further questions for the Minister. On which date did work begin on a response to the Hughes report? How many civil servants are working on the response? Have there been any conversations with the Treasury about the costs of the redress scheme? If work has been taking place, why is it invisible? If, in fact, nothing has been done, why have the Government persisted in telling Members that a response is forthcoming? Why, despite Dr Hughes visiting the Department in December, has nothing materially changed? Will the Government, as my hon. Friend the Member for North West Norfolk (James Wild) asked, make an interim payment this calendar year? Over the weekend, the Patient Safety Commissioner told ITV: “This is a disgraceful way that patients and families are being treated by those in power.” She is absolutely right. The state’s No. 1 duty is to protect the public from harm, yet after inflicting harm, the state has failed to make things right. This is part of a pattern under Labour whereby systemic failings, particularly those affecting women, go unresolved. Every day that victims of mesh and valproate do not receive justice, confidence in health professionals is undermined. We know that the Chancellor is fast running out of other people’s money, but it is wrong to balance the books on the backs of those who are suffering. Justice is the state’s duty. It is not optional. It is not something just to be carefully considered for years on end, indefinitely, while women and children suffer. The Government can respect the victims and the work of the Patient Safety Commissioner today by answering our questions, or they can continue their parade of platitudes and evasions. I look forward to the Minister’s response.

• 9 Feb 2026 · Brain Tumour Survival Rates · Hansard source

  More

  My right hon. Friend invites me to speak outside my area of expertise; I am afraid I do not know the answer to that.

• 9 Feb 2026 · Brain Tumour Survival Rates · Hansard source

  More

  It is certainly something that I have read about. I am happy to be corrected by the hon. Gentleman if he feels that my resources are incorrect, but that was certainly one of the suggestions for how to prevent these tumours. I do not think that prevention will necessarily be the major way in which we improve the survival rate. I also do not think that it will be early diagnosis, but I would like to finish talking about that. Regular screening for people with genetic disorders can really help to identify tumours early, and the second thing that can help is access to diagnostic tests. The Conservative Government introduced community diagnostic centres across the country, which increased the number of scanners available to those who needed a scan to identify whether they had a brain tumour. This Government have said that they will double the number of scanners available. Can the Minister comment on whether they are on track with that? We need the workforce plan, so that we have the people to perform and interpret the scans. I do not know whether the Minister has had any tips on whether the workforce plan is imminent, but can he give us a date for when it is likely to be published? It has been delayed, but it is important. We have the cancer plan, but so much of it is dependent on the workforce plan. Thirdly, opticians have a role to play. Since a South Tees project pioneered in 2015, opticians have been able, during regular eye tests, to identify people who have signs of brain tumours, and to refer them, when necessary. Encouraging people to get regular eye tests may contribute to early diagnosis. The fourth thing that can help with early diagnosis is symptom awareness—among both the general public and healthcare professionals. I want to talk about HeadSmart, a 2011 programme about the types of symptoms that could help identify a brain tumour. It had quite significant cut-through with both healthcare professionals and the public. It halved the time for a scan, and for diagnosis of children with brain tumours. It also improved the cognition of survivors, but it did not significantly improve the survival rate. While early diagnosis helps a bit, it is very difficult—particularly in children, who are quite neuroplastic, so symptoms appear quite late. The location and type of tumour are more important in the treatment and prognosis, and there are many different types. That makes this area of medicine extremely complicated, so I think the answer is that we need better treatments. Treatments currently include steroids, chemotherapy, radiotherapy and surgery, but there are many others with promise. Convection-enhanced delivery enables chemotherapy to be delivered across the blood-brain barrier more effectively. Many hon. Members have talked about freezing, and last month there was a debate on the topic of freezing brain tumour samples; does the Minister have an update following that debate? His colleague, the Under-Secretary of State for Health and Social Care, the hon. Member for West Lancashire (Ashley Dalton), said that she would look at the detail and report back, so I hope that he will have an update for us this evening. Gene therapy has also shown a lot of promise, and there has been talk this evening about the trial in which an adeno-associated virus is used as a vector to seek out the glioblastoma cells and use the patient’s immune system to kill the tumour cells. That trial has promise; if it works, it could lead to real improvements in treatment. Research will be key. BioNTech’s 2023 partnership promised that there would be 10,000 patients in cancer vaccine trials by 2030, but new innovators face barriers. This is a global fight; work is going on right across the globe, and we need to make the UK’s environment one that stimulates and supports research, so that British people can have the earliest possible access to the newest treatments. At the moment, the wider economic picture for research is not great, and we have seen some researchers pull out of investments in the UK. Taxation, national insurance, employment rules and the speed of adoption by the NHS are all factors that I hope the Minister will try to improve. The hon. Members for Edinburgh South West (Dr Arthur) and for Strangford (Jim Shannon) talked about the devolved Administrations. Could the Minister comment on how he and his team are working with those Administrations to encourage research right across the United Kingdom? I also wanted to talk about rural areas, because it is all very well encouraging trials in the UK or England, but so many of those trials are in the centre of London, or in the other big cities; it is much more difficult for people living in rural areas, such as my constituents in Sleaford and North Hykeham, to access them. Could the Minister please update the House on how he is making it easier for research to occur in rural spots? The hon. Member for Witney summed it up perfectly when he said that ambition is important, but actions, not words, are the key. We need specific, measurable targets, not just warm words—this Government have been very good at warm words on health, but much poorer on delivery. For the sake of the one in two people who will get cancer, and all their friends and loved ones, I hope that on this occasion, there is more action, not just words.

• 9 Feb 2026 · Brain Tumour Survival Rates · Hansard source

  More

  I will, particularly if the hon. Gentleman has an answer for my right hon. Friend.

• 9 Feb 2026 · Brain Tumour Survival Rates · Hansard source

  More

  I thank the hon. Members for Mitcham and Morden (Dame Siobhain McDonagh) and for Witney (Charlie Maynard) for bringing forward this debate on a very important subject. The hon. Member for Mitcham and Morden talked about the people she had met who had experienced brain cancer and brain tumours. For me, this debate is about my grandfather, who sadly died of a brain tumour some years ago. Some 12,000 people have a brain tumour diagnosed each year, and this debate is supposed to focus on how we improve the survival rates for this condition, which are very poor. It is the leading cause of cancer deaths among children and adults under 40. The five-year survival rate is poor and—unlike the rate for many other cancers over the last few years—has not really moved at all. How can we improve the survival rates for people with brain tumours? There are essentially three areas that we can look at: prevention, early diagnosis and better treatment. On prevention, if we look on the NHS website to see how we can prevent a brain cancer or brain tumour, it talks about having a good diet and preventing obesity. These things are important, but not specific to brain cancer. It also talks about trying to avoid head injury, for example by wearing helmets. What about early diagnosis? Some people have genetic conditions, such as neurofibromatosis, Li–Fraumeni syndrome, tuberous sclerosis and Von Hippel-Lindau syndrome, that make them genetically predisposed to having tumours in their central nervous system. Those individuals can receive regular screening, which can help identify these tumours at a much earlier stage, but what about people who do not have such conditions?

• 4 Feb 2026 · Engagements · Hansard source

  More

  I have been campaigning for a Lincoln dental school for some years. I am pleased to be able to tell the House that, thanks to the hard work of, among others, Professor Juster, Professor Read and Susie MacPherson, Lincoln medical school is now in a position to take on its first cohort from 2027. Will the Prime Minister provide the necessary funding for this cohort of students to start to help improve the oral health of people right across Lincolnshire?

• 4 Feb 2026 · Lord Mandelson · Hansard source

  More

  The Prime Minister said clearly today that when he appointed Peter Mandelson to the job as His Majesty’s ambassador, he knew that he had an ongoing relationship with the paedophile Epstein. Can the Minister tell us what sort of relationship he thinks would be acceptable when appointing such a person?

• 4 Feb 2026 · Lord Mandelson · Hansard source

  More

  The transparency point is really important. Peter Mandelson was a Labour politician and this is a Labour Government. It may be that Peter Mandelson was an isolated bad apple, and that no one knew anything about what he was doing until this document release last week, but the public will wonder, and they will question. If a Labour Government cover up things by being anything less than fully transparent, the public will wonder who they are covering up for, and why.

• 4 Feb 2026 · Lord Mandelson · Hansard source

  More

  The right hon. Lady is making strong and clear points about the relationship between Epstein and Mandelson. The Prime Minister was clear at Prime Minister’s questions that he knew the relationship was ongoing, and he knew that at the time he appointed him. What sort of ongoing relationship with a non-related convicted paedophile is acceptable to the right hon. Lady for someone who is meant to represent our country on the world stage?

• 2 Feb 2026 · Points of Order · Hansard source

  More

  On a point of order, Madam Deputy Speaker. I listened to the last debate carefully, and I wondered whether you could help me with a procedural question. Would it be orderly for the Government to bring forward legislation, as soon as they wished to do so, to relieve Peter Mandelson of his peerage?

• 2 Feb 2026 · US Department of Justice Release of Files · Hansard source

  More

  It is disgraceful that the Government are choosing not to bring forward legislation to remove Peter Mandelson from the House of Lords; it is entirely within their gift to do so. The public know that, and will be not only alarmed by the fact that the Government are not doing that, but questioning the motive for their delay. On what date exactly did Peter Mandelson cease to be paid by the Government?

• 28 Jan 2026 · Youth Unemployment · Hansard source

  More

  My hon. Friend is making an excellent speech, and I am sorry to interrupt it. I want to ask her about the people who are writing hundreds and hundreds of applications for graduate schemes, and who are finding that they are locked out of those schemes, having been deprioritised because of the colour of their skin. Why should the Deputy Prime Minister’s son or the children of the Leader of the Opposition be prioritised for jobs over a tractor driver from Lincolnshire?

• 28 Jan 2026 · Youth Unemployment · Hansard source

  More

  Will my hon. Friend comment on the proportion of benefits claimants who are under the age of 24? In Sleaford and North Hykeham, 25% of people on unemployment benefit are under the age of 24, which is clearly a very large amount.

• 28 Jan 2026 · Youth Unemployment · Hansard source

  More

  In the Minister’s speech, she seemed to be lauding jobs created by the Government. Does my hon. Friend agree that it is ridiculous to suggest that the Government should create jobs instead of business?